FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

FDA Urged to Expand Real-World Data Use

A bioethicists opinion piece in The Hill says FDA needs to expand its reliance on real-world clinical data to monitor the safety and effectiveness of ...

latest-news-card-1
Medical Devices

Multiple Insightra Medical Violations Cited

FDA warns Clarksville, TN-based Insightra Medical about multiple violations in its production of intra-aortic balloon pump catheter kits with specific...

latest-news-card-1
Human Drugs

FDA Study Finds Liver Risks Associated with CBD

A new FDA clinical trial finds that cannabidiol may cause liver enzyme elevations in otherwise healthy adults raising new concerns about the safety o...

latest-news-card-1
Medical Devices

Expanded Parkinsons Use OKd for Insightec Device

FDA approves an expanded indication for Insightecs Exablate Neuro platform for staged bilateral pallidothalamic tractotomy treatment in patients livin...

latest-news-card-1
Human Drugs

Priority Review for Mercks Winrevair

FDA accepts and will give priority review to a Merck sBLA for a Winrevair labeling update based on ZENITH trial results.

Biologics

Vaccine Regulation Now a Political Process: Gottlieb

Former FDA commissioner Scott Gottlieb raises significant questions about the current administrations handling of vaccines and vaccine innovation in w...

latest-news-card-1
Human Drugs

Sandoz Recalls 1 Cefazolin Lot

FDA says Sandoz has recalled one lot of Cefazolin for injection following a customer complaint that vials of another drug were included in a Cefazolin...

Medical Devices

FDA Clears Philips SmartSpeed Precise Software

FDA clears Philips SmartSpeed Precise AI-enhanced software for MRI systems.

latest-news-card-1
Human Drugs

Myelodysplastic Syndrome Drug Development Guide

FDA publishes a draft guidance to assist sponsors in developing drugs to treat myelodysplastic syndromes.

latest-news-card-1
Biologics

Positive Phase 3 Results for Moderna Flu Vaccine

Moderna says its mRNA-1010 investigational seasonal flu vaccine achieved very positive results in a Phase 3 efficacy trial.